# Cilostazol and Methotrexate in Rheumatoid Arthritis

> **NCT05594680** · PHASE3 · UNKNOWN · sponsor: **Tanta University** · enrollment: 70 (estimated)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** Cilostazol
- **DRUG:** Methotrexate
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05594680
- **Lead sponsor:** Tanta University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-10-01
- **Primary completion:** 2024-11-01
- **Final completion:** 2024-11-01
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2024-04-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05594680

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05594680, "Cilostazol and Methotrexate in Rheumatoid Arthritis". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT05594680. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*